Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page
- CheckyesterdayChange DetectedNew update dates for 2026 (2026-03-11, 2026-02-26, 2026-02) were added and older December 2025 dates were removed.SummaryDifference0.2%

- Check8 days agoChange DetectedAdded Moffitt Cancer Center Clinical Trials website and the institution name (H. Lee Moffitt Cancer Center and Research Institute) and included Helpful Links. Updated the site revision from v3.4.2 to v3.4.3.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe sponsor center name and the 'Helpful Links Provided by' block were removed from the study page.SummaryDifference0.2%

- Check30 days agoChange DetectedFooter revision updated: added Revision: v3.4.2 and removed Revision: v3.4.1.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded a 'Show glossary' toggle and updated the page revision header (Revision: v3.4.0), with minor capitalization tweaks to QC-related labels and FEAR Act wording.SummaryDifference0.2%

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.